Fludarabine-related myeloid leukemia

被引：7

作者：

Astrow, AB ^{[1
]}

机构：

[1] St Vincent Catholic Med Ctr, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 19期

关键词：

D O I：

10.1200/JCO.2003.99.090

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3709 / 3709

页数：1

相关论文

共 3 条

[1] Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy [J].

Coso, D ;

Costello, R ;

Cohen-Valensi, R ;

Sainty, D ;

Nezri, M ;

Gastaut, JA ;

Bouabdallah, R .

ANNALS OF ONCOLOGY, 1999, 10 (03) :362-363

[2] Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy [J].

Keating, MJ ;

O'Brien, S ;

Lerner, S ;

Koller, C ;

Beran, M ;

Robertson, LE ;

Freireich, EJ ;

Estey, E ;

Kantarjian, H .

BLOOD, 1998, 92 (04) :1165-1171

[3] Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011 [J].

Morrison, VA ;

Rai, KR ;

Peterson, BL ;

Kolitz, JE ;

Elias, L ;

Appelbaum, FR ;

Hines, JD ;

Shepherd, L ;

Larson, RA ;

Schiffer, CA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3878-3884